Not applicableEnded earlyNCT01083160
What this trial is testing
Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or Etanercept to Adalimumab in Patients With Active Rheumatoid Arthritis (RA). A Multicenter Post-Marketing Observational Study in Routine Clinical Use
Who this might be right for
Rheumatoid Arthritis
Abbott 82